BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16528092)

  • 1. Obesity, polycystic ovary syndrome, infertility treatment: asking obese women to lose weight before treatment increases stigmatisation.
    Laredo SE
    BMJ; 2006 Mar; 332(7541):609. PubMed ID: 16528092
    [No Abstract]   [Full Text] [Related]  

  • 2. Should obese women with polycystic ovary syndrome receive treatment for infertility?
    Balen AH; Dresner M; Scott EM; Drife JO
    BMJ; 2006 Feb; 332(7539):434-5. PubMed ID: 16497735
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of infertility in the polycystic ovary syndrome.
    Panidis D; Farmakiotis D
    N Engl J Med; 2007 May; 356(19):1999; author reply 2000-1. PubMed ID: 17494937
    [No Abstract]   [Full Text] [Related]  

  • 4. Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount.
    Lord JM; Norman R
    BMJ; 2006 Mar; 332(7541):609. PubMed ID: 16528093
    [No Abstract]   [Full Text] [Related]  

  • 5. Management ofanovulatory infertility associated with polycystic ovary syndrome (PCOS).
    Sukcharoen N
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S182-8. PubMed ID: 21213521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female obesity and assisted reproductive technologies.
    Kumbak B; Oral E; Bukulmez O
    Semin Reprod Med; 2012 Dec; 30(6):507-16. PubMed ID: 23074009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adverse effects of obesity on conception and implantation.
    Brewer CJ; Balen AH
    Reproduction; 2010 Sep; 140(3):347-64. PubMed ID: 20395425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and lifestyle management in polycystic ovary syndrome.
    Hoeger KM
    Clin Obstet Gynecol; 2007 Mar; 50(1):277-94. PubMed ID: 17304042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic infertility including polycystic ovary syndrome.
    Brassard M; AinMelk Y; Baillargeon JP
    Med Clin North Am; 2008 Sep; 92(5):1163-92, xi. PubMed ID: 18721657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
    Saleh AM; Khalil HS
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycystic ovary syndrome I. Clinical presentation and treatment].
    Ovesen PG; Møller N; Greisen S; Ingerslev HJ
    Ugeskr Laeger; 1998 Jan; 160(3):260-4. PubMed ID: 9454393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of infertility in polycystic ovary syndrome: a brief update.
    Costello MF; Misso ML; Wong J; Hart R; Rombauts L; Melder A; Norman RJ; Teede HJ
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):400-3. PubMed ID: 22639834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and infertility.
    Pasquali R; Patton L; Gambineri A
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):482-7. PubMed ID: 17982356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [When and how should polycystic ovary syndrome be treated?].
    Martikainen H
    Duodecim; 2001; 117(13):1323-7; quiz 1327, 1341. PubMed ID: 12184121
    [No Abstract]   [Full Text] [Related]  

  • 16. Achieving a successful pregnancy in women with polycystic ovary syndrome.
    Araki T; Elias R; Rosenwaks Z; Poretsky L
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):865-94. PubMed ID: 22108285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood and sexual function in polycystic ovary syndrome.
    Janssen OE; Hahn S; Tan S; Benson S; Elsenbruch S
    Semin Reprod Med; 2008 Jan; 26(1):45-52. PubMed ID: 18181082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
    Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
    Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction.
    Kaya C; Pabuccu R; Satıroglu H
    Fertil Steril; 2010 Nov; 94(6):2202-7. PubMed ID: 20138267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preconceptual contraception paradigm: obesity and infertility.
    Nelson SM; Fleming RF
    Hum Reprod; 2007 Apr; 22(4):912-5. PubMed ID: 17172282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.